Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
YesterdayDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
YesterdayRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
YesterdayThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
YesterdayBuffalo Potash Files Annual Information Form and New Technical Report
YesterdayIonik Announces 30-Day Extension of Senior Debt Facility
Briacell Therapeutics Corp logo

Briacell Therapeutics Corp

About

4.79CAD-0.26 -5.15%
Closed • Updated at 16:51 GMT+00:00
Market Cap$25.20M
Volume20.9K
Beta1.36
RSI41.35
Health TechnologyBiotechnology

Briacell Therapeutics Corp — investor relations, events, news, and company updates on 6ix.

Latest News

May 22 2026
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
May 15 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+(TM)
May 14 2026
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+(TM) for Prostate Cancer
May 13 2026
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 12 2026
BriaCell Phase 3 Bria-IMT(TM) Study Enrollment Surpasses 230 Patients

Community Chat

Ask AI

Try asking
6ix6ixAIEvents